Effect of taxanes following anthracyclines on pathologic complete response (pCR) in patients with triple-negative breast cancer (TNBC) receiving primary systemic therapy (PST)

Authors :: D. Angelucci
Stefano Iacobelli
Antonino Grassadonia
Clara Natoli
N. Tinari
Jamara Giampietro
Ettore Cianchetti
Marinella Zilli
Maria Teresa Scognamiglio
S. Gildetti
Source :: Journal of Clinical Oncology. 28:e13129-e13129
Publication Year :: 2010
Publisher :: American Society of Clinical Oncology (ASCO), 2010.
Abstract: e13129 Background: TNBC is an aggressive molecular subtype associated with increased risk of distant metastases and poor prognosis. In this study we report response to PST and clinical outcome of a...

Subjects :: Oncology
Cancer Research
Poor prognosis
medicine.medical_specialty
business.industry
food and beverages
Systemic therapy
Increased risk
Internal medicine
medicine
In patient
business
Triple-negative breast cancer
Complete response

Tools